Abstract
Most therapeutic options for PoTS are covered in other chapters on pharmacological approaches in this text book; however patients with PoTS may continue to be symptomatic despite being treated with a combination of volume expander (fludrocortisone) and vasoconstrictor (midodrine). Here consideration is limited to four additional classes of therapy which may be of benefit when conventional approaches have failed:
-
Anti-diuretic treatment (Desmopressin)
-
Acetylcholinesterase inhibition (pyridostigmine)
-
Colony stimulating factors (erythropoietin)
-
Selective serotonin reuptake inhibitors (SSRI).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Richardson DW, Robinson AG. Desmopressin. Ann Intern Med. 1985;103(2):228–39.
Ahmad RA, Watson RD. Treatment of postural hypotension. Rev Drugs. 1990;39(1):74–85.
Coffin ST, Black BK, Biaggioni I, Paranjape SY, Orozco C, Black PW, et al. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012;9(9):1484–90.
Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127(23):2336–42.
Gales BJ, Gales MA. Pyridostigmine in the treatment of orthostatic intolerance. Annals Pharmacoth. 2007;41(2):314–8.
Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation. 2005;111(21):2734–40.
Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B, et al. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophy. 2011;34(6):750–5.
Elliott S, Pham E, Macdougall IC. Erythropoietins: a common mechanism of action. Exp Hematol. 2008;36(12):1573–84.
Fishbane S, Besarab A. Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. Clin J Am Soc Nephrol. 2007;2(6):1274–82.
Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120(10):841–7.
Hoeldtke RD, Horvath GG, Bryner KD. Treatment of orthostatic tachycardia with erythropoietin. Am J Med. 1995;99(5):525–9.
Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Sheikh M, Grubb BP. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome. Am J Ther. 2012;19(2):92–5.
Guzman JC, Armaganijan LV, Morillo CA. Treatment of neurally mediated reflex syncope. Cardiol Clin. 2013;31(1):123–9.
Sharma T, Guski LS, Freund N, Gotzsche PC. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ. 2016;352:i65.
Grubb BP. Postural tachycardia syndrome. Circulation. 2008;117(21):2814–7.
Mar PL, Raj V, Black BK, Biaggioni I, Shibao CA, Paranjape SY, et al. Acute haemodynamic effects of a selective serotonin reuptake inhinitor in postural tachycardia syndrome: a radnomized crossover trial. J Psychopharmacol. 2014;28(2):155–61.
Green EA, Raj V, Shibao CA, Biaggioni I, Black BK, Dupont WD, et al. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc. 2013;2(5):e000395.
Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar. J Am Coll Cardiol. 2019;73(10):1207–28.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Asgari, M., Lobo, M.D. (2021). Other Medications: Desmopressin, Pyridostigmine, Erythropoietin and SSRIs. In: Gall, N., Kavi, L., Lobo, M.D. (eds) Postural Tachycardia Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-54165-1_34
Download citation
DOI: https://doi.org/10.1007/978-3-030-54165-1_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54164-4
Online ISBN: 978-3-030-54165-1
eBook Packages: MedicineMedicine (R0)